ZyVersa Therapeutics, Inc.
ZVSA · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q1 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Cashmere Karen A.: Form 4
Insider disclosure · Filed · Report period 11 Jul 2025
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001859007 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ZVSA on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2436 North Federal Highway, Suite 466, Lighthouse Point, FL, 33064
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Larkspur Health Acquisition Corp. (to 09 Dec 2022)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields